Phanes Therapeutics, Inc. (Phanes), a clinical stage biotech company focused on innovative drug discovery and development in oncology, announced today that the first patient has been dosed in the ...

引言胃神经内分泌肿瘤（gastric neuroendocrine neoplasms，G-NENs）相对罕见，不足所有神经内分泌肿瘤（NENs）的 2%，占所有胃癌的 < 1%[1]。胃混合性神经内分泌-非神经内分泌肿瘤（gastric mixed ...

Illinois state senators are considering allowing doctors to prescribe lethal doses of medicine. Dozens of people gathered in Chicago the the first hearing of Senate Bill 9, the End of Life Options Act ...

Jordie Poncy was diagnosed with a rare form of cancer just as he was preparing to start a new counseling job at Moffitt ...

Single mother-of-three Sheree Fiorita went to Modbury hospital thinking at worst she had kidney stones, she had no idea she ...

Kauvery Hospital Vadapalani, a leading healthcare institution renowned for its advanced surgical techniques, has performed a ...

Exelixis’ next-generation tyrosine kinase inhibitor zanzalintinib is being tested for colorectal cancer, renal cell carcinoma ...

Gastric Neuroendocrine Tumors market Forecast. DelveInsight's Gastric Neuroendocrine Tumors Market report offers an in-depth understanding of the epidemiol ...

The European Commission granted approval for von Hippel-Lindau-associated renal cell carcinoma, CNS hemangioblastomas, or pancreatic neuroendocrine tumors.

On Tuesday, the European Commission (EC) conditionally approved Merck & Co Inc’s (NYSE:MRK) Welireg (belzutifan), an oral ...

Market was valued at USD 1564 Million in 2023 and is anticipated to reach USD 5374 Million by 2030, witnessing a CAGR of 16.9% during the forecast period 2024-2030. Claim Your Free ...

The EC has conditionally approved MSD's Welireg as a single agent for the treatment of adults with VHL disease and advanced ...